Group introduction: Heiske Group has strong technical force and a professional scientific research team with solid theoretical foundation, rich experience and outstanding innovation ability. And has an independent R&D building and test factory. Up to now, R&D Center has developed 22 new drugs (including products with technology transfer) for the company, which are widely used in parenteral nutrition, anti-infection, digestive system, nervous system and other fields. Among them, invert sugar injection, sodium fusidate for injection, polyene phosphatidylcholine injection and fat-soluble vitamins for injection have been included in the national medical insurance catalogue, covering more than 70% of the third-class first-class hospitals in China, and